Neuroimaging
Section Head
Dr. José N. Nobrega
Research Objective
The neurochemical basis of neuropsychiatric illness and mechanisms of drug actions are investigated, using animal models and
brain imaging techniques, to advance basic and applied knowledge of mental illnesses and addictive behaviours.
Summary of Activities
Research in the Neuroimaging Section is aimed at mapping changes in specific brain areas, neuroanatomical pathways and chemical
mechanisms in neuropsychiatric disorders primarily through detailed analyses in anatomically preserved brains from animals.
Models of depression and stress reactions
The learned helplessness model of depression continues to be used to test animals showing a propensity to develop depressive-type
symptoms in response to stress. Significant changes in gene expression have been identified in the forebrain of stress-susceptible
and stress-resistant animals.
In the context of stress reactions, scientists continue to study sleep deprivation, to identify possible mechanisms involved
in its beneficial (antidepressant) effects as well as its potentially harmful effects. Collaboration with scientists at the
Federal University of São Paulo, Brazil has led to the identification of changes in the brain expression of specific subtypes
of thyroid hormone receptors in the chronic mild stress model of depression, suggesting a potential involvement of these receptors
in antidepressant effects.
Models of antipsychotic drug action
In a major collaborative effort with CAMH colleagues aimed at understanding brain mechanisms underlying differences between
newer and older types of antipsychotic drugs, scientists are studying early gene (c-fos) activation induced by several drugs
in conjunction with receptor occupancy and behavioural measures. Long-term motor side-effects induced by long-term treatment
with classic antipsychotic medications are an important clinical problem. Using the vacuous chewing movement (VCM) model of
tardive dyskinetic syndromes, scientists have found that the emergence of motor side-effects may depend crucially on the regimen
of drug administration and may be reversed by targeting specific serotonin or adenosine receptors. Brain changes occurring
in another chronic movement disorder model, the dtsz mutant hamster, are also mapped using brain imaging techniques. This work is being carried out in collaboration Dr. A. Richter in Berlin,
Germany.
Brain mechanisms of compulsive drug-taking
Repeated exposure to drugs of abuse results in an increased sensitivity to their behavioral effects. Brain mechanisms underlying
differential susceptibility to behavioural sensitization to alcohol continue to be an important focus of research. Work with
dopamine receptor knockout (KO) mice, which lack specific types of dopamine receptors by inactivating or "knocking out" the
genes for the receptors in mouse embryos, indicates that D1 and D3 receptors, but not D2 receptors may be critical for behavioural sensitization to ethanol.